Satsuma Pharmaceuticals Inc Ordinary Shares (NASDAQ:STSA)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - STSA
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - STSA
- Market Cap$89.380m
- SymbolNASDAQ:STSA
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS80405P1075
Company Profile
Satsuma Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product for the treatment of migraine. Its product candidate, STS101, is a drug-device combination of a dry-powder formulation of dihydroergotamine mesylate, or DHE, which can be self-administered with a pre-filled, single-use, nasal delivery device.
Latest STSA news
Currently there for this company. Visit our news hub for other news .